吡柔比星为主的联合化疗方案治疗老年非霍奇金淋巴瘤临床研究(1)
| 第1页 |
参见附件。
[摘要] 目的:观察吡柔比星为主的联合化疗方案(CTOP方案)治疗老年非霍奇金淋巴瘤(NHL)的临床疗效。方法:将我院2008年2月～2009年4月收治的61例老年NHL患者随机分为观察组(31例)和对照组(30例),分别采用CTOP方案和CHOP方案治疗。结果:观察组的完全缓解率高于对照组,两组差异有统计学意义(P<0.05);观察组的不良反应发生率低于对照组,两组差异有统计学意义(P<0.05)。结论:CTOP方案治疗老年NHL疗效满意,且不良反应少,是目前治疗老年NHL的理想方法之一。
[关键词] 非霍奇金淋巴瘤;老年;吡柔比星;阿霉素;化疗
[中图分类号] R551.2[文献标识码]A [文章编号]1673-7210(2010)02(a)-009-02
Clinical study of CTOP regimen in the treatment of aged patients with NHL
ZHANG Yusheng
(The First People's Hospital of Shangqiu City, He'nan Province, Shangqiu 476000, China)
[Abstract] Objective: To investigate the therapeutic effects of CTOP regimen in the treatment of aged patients with NHL. Methods: 61 aged patients with NHL from February 2008 to April 2009 in our hospital were randomly divided into observation group (n=31) and control group (n=30), and they were treated with CTOP regimen and CHOP regimen respectively ......
您现在查看是摘要介绍页，详见PDF附件。